Likarda is a cell therapy company developing enabling technologies for the delivery of cell therapies to improve their efficacy and provide patients with sustainable reversal for their chronic or fatal diseases. Likarda’s revolutionary technology to coat cells with inert hydrogels, called Core-Shell Spherification® (CSS™), is a customizable platform to deliver and maintain cells in their intended target location within the body, while keeping cells viable by protecting them from destruction.